₹ 216.73
0.48 (0.22%)
J
Jagsonpal Pharmaceuticals
₹ 216.73
JAGSNPHARM Financials Summary (Consolidated)
Jagsonpal Pharmaceuticals revenue increased 15.86% quarter-on-quarter to ₹99 Cr in Sep 2026, while net profit decreased 6.82% quarter-on-quarter to ₹12 Cr. EPS for the quarter stood at ₹1.86, decreased from ₹2.00 in the previous quarter.
Jagsonpal Pharmaceuticals Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of JAGSNPHARM Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
JAGSNPHARM Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






